Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 4/20 | 0.53 |
| ▸ | WDR77 | Q9BQA1 | 4/20 | 0.53 |
| ▸ | SCD | O00767 | 2/20 | 0.49 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.43 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | SCD5 | Q86SK9 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27574934 | 0.85 | RIPK1 (0.62) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL216202 | 0.85 | RIPK1 (0.62) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL27574946 | 0.85 | RIPK1 (0.62) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| Water SCHEMBL27700791 | 0.83 | RIPK1 (0.60) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL20449190 | 0.83 | SCD (0.46) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL20528487 | 0.83 | SCD (0.46) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL1197375 | 0.81 | HSD11B1 (0.51) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL29892279 | 0.81 | CCNC (0.51) | RIPK1HSD11B1SCD5ALDH1A1KMT2A | |
| SCHEMBL1197373 | 0.81 | SCD (0.49) | PRMT5WDR77SCDRIPK1HSD11B1 | |
| SCHEMBL14920930 | 0.81 | HSD11B1 (0.54) | RIPK1HSD11B1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116497411-A | Cyanide-free alkaline silver plating electroplating solution and preparation and application thereof | 上海电力大学 | 2023-07-28 | — | — | CN | claimed |
| CN-116497411-A | Cyanide-free alkaline silver plating electroplating solution and preparation and application thereof | 上海电力大学 | 2023-07-28 | — | — | CN | disclosed |
| US-20020173518-A1 | Antithrombotic agents | BEIGHT DOUGLAS WADE (US) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173518-A1 | Antithrombotic agents | SERPINC1, TFPI, F11 | PRMT5 4201/4885WDR77 3565/4885SCD 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.